Short-Term Observation of Ultrasonic Cyclocoagulation in Chinese Patients with End-Stage Refractory Glaucoma: A Retrospective Study

Table 2

IOP levels at return visits for two groups of patients.

Groups	FU		IOP (mmHg)		IOP range	IOP reduction (%)	Number of medications
6 sectors	Baseline	43	40.07 ± 10.18	—	22–59	—	2.6 ± 1.1	—
	D1	41	30.91 ± 10.09	<0.001	11–55	22.20	2.6 ± 1.1	1
	D7	43	25.42 ± 11.14	<0.001	8–48.3	36.60	2.6 ± 1.1	1
	M1	42	28.34 ± 12.92	<0.001	8.3–57.7	29.40	2.6 ± 1.2	0.589
	M3	34	31.65 ± 12.56	<0.001	2–55	22	2.4 ± 1.2	0.34
8 sectors	Baseline	18	43.59 ± 11.62	—	26–64	—	2.7 ± 0.7	—
	D1	18	25.02 ± 9.24	<0.001	5–36	42	2.7 ± 0.7	1
	D7	18	18.46 ± 10.66	<0.001	4.3–36.7	57.70	2.7 ± 0.7	1
	M1	17	22.98 ± 10.15	<0.001	9–40.3	50.20	2.6 ± 0.7	0.317
	M3	17	31.59 ± 18.44	0.019	3–79	28.50	2.3 ± 1.1	0.038

D1: day 1; D7: day 7; M1: month 1; M3: month 3; IOP: intraocular pressure. ^&Paired t-test, compared to baseline IOP; Wilcoxon’s test.